06.02.2019
- German and British drugmakers Merck KGaA and Glaxo SmoithKline have entered a global strategic alliance to jointly develop and commercialize M7824 (bintrafusp alfa), the German...
14.12.2018
- US biopharma AVEO Oncology is collaborating with Anglo-Swedish drug major AstraZeneca on a combined treatment for liver cancer. The partners will evaluate the safety and efficacy...
01.03.2018
- The US Food and Drug Administration (FDA) has approved AstraZeneca and MedImmune’s immunotherapy Imfinzi (durvalumab) to treat patients with a certain form of lung cancer. Imfinzi...
07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
04.12.2017
- AstraZeneca and GI Therapeutics, a US clinical-stage oncology company, are collaborating to test a new combination therapy for lung cancer. The parties will evaluate AstraZeneca’s...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
20.11.2017
- US healthcare giant Johnson & Johnson (J&J) has won another victory in a string of lawsuits claiming its talc-based baby powder causes cancer. The jury in the state of California...
09.11.2017
- The US Food and Drug Administration has approved a new drug developed by Eli Lilly to treat a common type of breast cancer. Verzenio is recommended both for women and men with HR...
